Allergy to human insulin and specific immunotherapy with glargine; case report with review of literature

[1]  B. Akıncı,et al.  Allergic reactions to human insulin: a review of current knowledge and treatment options , 2010, Endocrine.

[2]  Y. Izumida,et al.  Successful desensitization by glargine administration in a patient with insulin allergy: a case report. , 2009, Diabetes research and clinical practice.

[3]  K. Niswender.  Early and Aggressive Initiation of Insulin Therapy for Type 2 Diabetes: What Is the Evidence? , 2009, Clinical Diabetes.

[4]  R. Reisman.  Clinical Significance of Insulin Allergy and Insulin Resistance Studies: Application to Drug “Desensitization” Concept and Efficacy , 2009 .

[5]  M. A. Mollar-Puchades,et al.  Insulin glulisine in the treatment of allergy to rapid acting insulin and its rapid acting analogs. , 2009, Diabetes research and clinical practice.

[6]  M. Baxter.  The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes , 2008, Acta Diabetologica.

[7]  W. Tilgen,et al.  Successful desensitization with human insulin in a patient with an insulin allergy and hypersensitivity to protamine: a case report , 2008, Journal of medical case reports.

[8]  H. Tian,et al.  Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial , 2008, The Lancet.

[9]  G. Sundkvist,et al.  Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4‐year follow‐up , 2008, Diabetes, obesity & metabolism.

[10]  T. Zuberbier,et al.  Insulin allergy: clinical manifestations and management strategies , 2008, Allergy.

[11]  Li Zhang,et al.  Insulin as an autoantigen in NOD/human diabetes. , 2008, Current opinion in immunology.

[12]  K. Gungor,et al.  Severe anaphylactic reaction to human insulin in a diabetic patient. , 2007, Journal of diabetes and its complications.

[13]  T. Chowdhury,et al.  Insulin allergy in a patient with Type 2 diabetes successfully treated with continuous subcutaneous insulin infusion , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[14]  M. Asai,et al.  Immunologic tolerance to intravenously injected insulin. , 2006, The New England journal of medicine.

[15]  Nhs Trust.  Severe adverse cutaneous reaction to insulin due to cresol sensitivity , 2006 .

[16]  T. Schöndorf,et al.  Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepiride. , 2006, Metabolism: clinical and experimental.

[17]  V. Matheu,et al.  Insulin allergy and resistance successfully treated by desensitisation with Aspart insulin , 2005, Clinical and molecular allergy : CMA.

[18]  R. Heine,et al.  [Insulin allergy: background, diagnosis and treatment]. , 2005, Nederlands tijdschrift voor geneeskunde.

[19]  C. Kara,et al.  Successful treatment of insulin allergy in a 1-year-old infant with neonatal diabetes by lispro and glargine insulin. , 2005, Diabetes care.

[20]  Xu Jixiong,et al.  The human insulin analog aspart can induce insulin allergy. , 2004, Diabetes care.

[21]  N. Levitt,et al.  A case of generalised allergic reaction to human insulin , 2004 .

[22]  B. Bartolomé,et al.  Allergy to human insulin , 2003, Allergy.

[23]  S. Fukumoto,et al.  Insulin allergy; desensitization with crystalline zinc-insulin and steroid tapering. , 2003, Diabetes research and clinical practice.

[24]  C. Pecquet,et al.  Glargine insulin is not an alternative in insulin allergy. , 2003, Diabetes care.

[25]  P. Tornero,et al.  Systemic allergic reaction by a human insulin analog , 2003, Allergy.

[26]  G. Watts,et al.  Docosahexaenoic acid but not eicosapentaenoic acid increases LDL particle size in treated hypertensive type 2 diabetic patients. , 2003, Diabetes care.

[27]  Y. Ikeda,et al.  The human insulin analogue aspart is not the almighty solution for insulin allergy. , 2003, Diabetes care.

[28]  R. Gomis,et al.  Continuous subcutaneous insulin infusion to resolve an allergy to human insulin. , 2002, Diabetes care.

[29]  O. Kordonouri,et al.  Lipohypertrophy in young patients with type 1 diabetes. , 2002, Diabetes care.

[30]  Joon-Hyuk Choi,et al.  Insulin-induced drug eruptions and reliability of skin tests. , 2002, Acta dermato-venereologica.

[31]  A. Tedeschi,et al.  The insulin analog aspart: a safe alternative in insulin allergy. , 2001, Diabetes care.

[32]  R. Wood,et al.  Protamine allergy as a complication of insulin hypersensitivity: A case report. , 1999, The Journal of allergy and clinical immunology.

[33]  T. Carrillo,et al.  Ananhvlaxis to subcutaneous neutral motarnine Hagedorn insulin with simultaneous knsitization to protamine and insulin , 1996 .

[34]  T. Carrillo,et al.  Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin. , 1996, Allergy. European Journal of Allergy and Clinical Immunology.

[35]  G. Schernthaner,et al.  Immunogenicity and Allergenic Potential of Animal and Human Insulins , 1993, Diabetes Care.

[36]  C. Lewis,et al.  What Is The Evidence? , 2009 .